Article Details
Retrieved on: 2018-04-09 14:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Sangamo Therapeutics logo <b>BlackRock Inc</b>. boosted its position in shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) by 2.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,871,509 shares of the biopharmaceutical ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here